☰

Matthew J. Christopher, Ph.D. - Publications

Affiliations: 
2010 Biology & Biomedical Sciences (Molecular Cell Biology) Washington University, Saint Louis, St. Louis, MO 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ferraro F, Miller CA, Christensen KA, Helton NM, O'Laughlin M, Fronick CC, Fulton RS, Kohlschmidt J, Eisfeld AK, Bloomfield CD, Ramakrishnan SM, Day RB, Wartman LD, Uy GL, Welch JS, ... Christopher MJ, et al. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34845035 DOI: 10.1073/pnas.2116427118  0.76
2021 Christopher MJ, Katerndahl CDS, LeBlanc HR, Elmendorf TT, Basu V, Gang M, Menssen AJ, Spencer DH, Duncavage EJ, Ketkar S, Wartman LD, Ramakrishnan SM, Miller CA, Ley TJ. Tumor suppressor function of in acute promyelocytic leukemia. Haematologica. PMID 34670359 DOI: 10.3324/haematol.2021.279601  0.553
2021 Duncavage EJ, Schroeder MC, O'Laughlin M, Wilson R, MacMillan S, Bohannon A, Kruchowski S, Garza J, Du F, Hughes AEO, Robinson J, Hughes E, Heath SE, Baty JD, Neidich J, ... Christopher MJ, et al. Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers. The New England Journal of Medicine. 384: 924-935. PMID 33704937 DOI: 10.1056/NEJMoa2024534  0.703
2019 Christopher M, DiPersio JF, Ley TJ. Immune Escape of AML Cells after Transplantation. Reply. The New England Journal of Medicine. 380: 1290. PMID 30917273 DOI: 10.1056/NEJMc1900424#sa3  0.607
2018 Christopher MJ, Petti AA, Rettig MP, Miller CA, Chendamarai E, Duncavage EJ, Klco JM, Helton NM, O'Laughlin M, Fronick CC, Fulton RS, Wilson RK, Wartman LD, Welch JS, Heath SE, et al. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation. The New England Journal of Medicine. PMID 30380364 DOI: 10.1056/Nejmoa1808777  0.772
2018 Duncavage EJ, Jacoby MA, Chang GS, Miller CA, Edwin N, Shao J, Elliott K, Robinson J, Abel H, Fulton RS, Fronick CC, O'Laughlin M, Heath SE, Brendel K, Saba R, ... ... Christopher MJ, et al. Mutation Clearance after Transplantation for Myelodysplastic Syndrome. The New England Journal of Medicine. 379: 1028-1041. PMID 30207916 DOI: 10.1056/Nejmoa1804714  0.774
2018 Chen D, Christopher M, Helton NM, Ferguson I, Ley TJ, Spencer DH. DNMT3A-associated hypomethylation patterns are maintained in primary AML xenografts, but not in the DNMT3AOCI-AML3 leukemia cell line. Blood Cancer Journal. 8: 38. PMID 29618788 DOI: 10.1038/S41408-018-0072-9  0.62
2017 Christopher M, Menssen A, Gang M, Upadhyaya A, Wartman LD, Ley TJJ. Expression of the Tumor Suppressor WT1 Is Induced By PML-Rara in Acute Promyelocytic Leukemia.  Blood. 130: 2508-2508. DOI: 10.1182/Blood.V130.Suppl_1.2508.2508  0.478
2016 Griffith M, Griffith OL, Krysiak K, Skidmore ZL, Christopher MJ, Klco JM, Ramu A, Lamprecht TL, Wagner AH, Campbell KM, Lesurf R, Hundal J, Zhang J, Spies NC, Ainscough BJ, et al. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B lymphoblastic leukemia. Experimental Hematology. PMID 27181063 DOI: 10.1016/J.Exphem.2016.04.011  0.77
2016 Christopher M, Petti AA, Miller C, Wartman LD, Payton JE, Heath S, Fulton R, Welch JS, Walter MJ, Westervelt P, Link DC, Wilson RK, Ley TJ, DiPersio JF. Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation Blood. 128: 1528-1528. DOI: 10.1182/Blood.V128.22.1528.1528  0.771
2015 Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, Wartman LD, Christopher M, Lamprecht TL, Helton NM, Duncavage EJ, Payton JE, Baty J, Heath SE, Griffith OL, et al. Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. Jama. 314: 811-22. PMID 26305651 DOI: 10.1001/Jama.2015.9643  0.759
2015 Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, Wartman LD, Christopher M, Lamprecht TL, Payton JE, Baty J, Heath SE, Griffith OL, Shen D, Hundal J, et al. Abstract PR11: Genomic approaches for risk assessment in acute myeloid leukemia Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Pr11  0.748
2015 Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, Wartman LD, Christopher M, Lamprecht TL, Payton JE, Baty J, Heath SE, Griffith OL, Shen D, Hundal J, et al. Abstract PR03: Genomic approaches for risk assessment in acute myeloid leukemia Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-Pr03  0.747
2014 Sarkaria SM, Christopher MJ, Klco JM, Ley TJ. Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro. Leukemia. 28: 2403-6. PMID 25092143 DOI: 10.1038/Leu.2014.235  0.642
2014 Schuettpelz LG, Borgerding JN, Christopher MJ, Gopalan PK, Romine MP, Herman AC, Woloszynek JR, Greenbaum AM, Link DC. G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling. Leukemia. 28: 1851-60. PMID 24518205 DOI: 10.1038/Leu.2014.68  0.783
2013 Greenbaum A, Hsu YM, Day RB, Schuettpelz LG, Christopher MJ, Borgerding JN, Nagasawa T, Link DC. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature. 495: 227-30. PMID 23434756 DOI: 10.1038/Nature11926  0.784
2013 Schuettpelz LG, Borgerding JN, Gopalan P, Christopher M, Romine M, Woloszynek J, Greenbaum A, Link DC. G-CSF Treatment Induces Toll-Like Receptor Signaling and Regulates Hematopoietic Stem Cell Function Blood. 122: 1181-1181. DOI: 10.1182/Blood.V122.21.1181.1181  0.798
2012 Hsu YS, Greenbaum A, Schuettpelz LG, Christopher M, Borgerding JN, Day RB, Nagasawa T, Link DC. CXCL12 Production by Early Mesenchymal Progenitors Is Required for Hematopoietic Stem Cell Maintenance Blood. 120: 510-510. DOI: 10.1182/Blood.V120.21.510.510  0.784
2012 Borgerding JN, Gopalan P, Christopher M, Link DC, Schuettpelz LG. G-CSF Treatment Induces Hematopoietic Stem Cell Quiescence but Loss of Repopulating Activity Blood. 120: 1206-1206. DOI: 10.1182/Blood.V120.21.1206.1206  0.756
2011 Christopher MJ, Rao M, Liu F, Woloszynek JR, Link DC. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. The Journal of Experimental Medicine. 208: 251-60. PMID 21282380 DOI: 10.1084/Jem.20101700  0.803
2009 Christopher MJ, Liu F, Hilton MJ, Long F, Link DC. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood. 114: 1331-9. PMID 19141863 DOI: 10.1182/Blood-2008-10-184754  0.733
2009 Rao M, Christopher M, Woloszynek J, Liu F, Link DC. Expression of the G-CSF Receptor in Monocytes Is Sufficient to Mediate Osteoblast Suppression and HSPC Mobilization by G-CSF in Mice. Blood. 114: 563-563. DOI: 10.1182/Blood.V114.22.563.563  0.789
2008 Christopher MJ, Link DC. Granulocyte colony-stimulating factor induces osteoblast apoptosis and inhibits osteoblast differentiation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 23: 1765-74. PMID 18597629 DOI: 10.1359/Jbmr.080612  0.729
2008 Christopher M, Link DC. Bone Marrow Monocyte/Macrophages Provide Signals Necessary for Osteoblast Maintenance: Potential Role for Insulin-Like Growth Factor Signaling Blood. 112: 323-323. DOI: 10.1182/Blood.V112.11.323.323  0.739
2008 Gopalan PK, Christopher MJ, Greenbaum AM, Link DC. Disruption of the Osteoblast Niche by G-CSF Is Associated with Hematopoietic Stem Cell Quiescence and Loss of Long-Term Repopulating Activity: Role of Cdkn1a Blood. 112: 2447-2447. DOI: 10.1182/Blood.V112.11.2447.2447  0.809
2007 Christopher MJ, Link DC. Regulation of neutrophil homeostasis. Current Opinion in Hematology. 14: 3-8. PMID 17133093 DOI: 10.1097/00062752-200701000-00003  0.674
2007 Gopalan PK, Christopher MJ, Link DC. Disruption of the Osteoblast Niche by G-CSF Induces Hematopoietic Stem Cell Quiescence and Loss of Long-Term Repopulating Activity. Blood. 110: 2217-2217. DOI: 10.1182/Blood.V110.11.2217.2217  0.743
2006 Christopher MJ, Gopalan PK, Link DC. G-CSF Disrupts the Stem Cell Niche by Increasing Turnover of Bone Marrow Osteoblasts. Blood. 108: 87-87. DOI: 10.1182/Blood.V108.11.87.87  0.726
2005 Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I, Levesque JP, Chappel J, Ross FP, Link DC. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood. 106: 3020-7. PMID 16037394 DOI: 10.1182/Blood-2004-01-0272  0.805
2005 Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I, Levesque J, Link DC. G-CSF Potently Suppresses Osteoblast Activity in the Bone Marrow. Blood. 106: 591-591. DOI: 10.1182/Blood.V106.11.591.591  0.746
2004 Christopher MJ, Liu F, Everly N, Link DC. Disruption of SDF-1/CXCR4 Signaling during Flt-3 Ligand and Stem Cell Factor (SCF) Induced Hematopoietic Progenitor Mobilization. Blood. 104: 4139-4139. DOI: 10.1182/Blood.V104.11.4139.4139  0.693
Show low-probability matches.